New diabetes clinical trial: Efficacy and Safety of Bifidobacterium Quadruple Live Tablets in Patients With T2DM and Constipation
Published on: July 29, 2021 at 09:30PM
Condition: Type 2 Diabetes Mellitus With Complication
Interventions: Drug: Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live; Drug: Siliankang simulating tablets
Sponsors: Peking Union Medical College Hospital; First Affiliated Hospital of Harbin Medical University; The Affiliated Hospital of Inner Mongolia Medical University; Affiliated Hospital of Chengde Medical University; The First Affiliated Hospital of Zhengzhou University; Chinese Academy of Sciences; Hangzhou Grand Biologic Pharmaceutical, Inc.
Not yet recruiting
https://ift.tt/3lh8YKm
Condition: Type 2 Diabetes Mellitus With Complication
Interventions: Drug: Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live; Drug: Siliankang simulating tablets
Sponsors: Peking Union Medical College Hospital; First Affiliated Hospital of Harbin Medical University; The Affiliated Hospital of Inner Mongolia Medical University; Affiliated Hospital of Chengde Medical University; The First Affiliated Hospital of Zhengzhou University; Chinese Academy of Sciences; Hangzhou Grand Biologic Pharmaceutical, Inc.
Not yet recruiting
https://ift.tt/3lh8YKm
Comments
Post a Comment